Effect of oral administration of Hypericum perforatum extract (St. John's wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation

Phytotherapy Research

Volumn 17, Issue 2, 2003, Pages 141-146

  Schempp, Christoph M ^a,c   Winghofer, Barbara ^a   Müller, Knut ^a   Schulte Mönting, Jürgen ^a   Mannel, Marcus ^b   Schöpf, Erwin ^a   Simon, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Lichtwer Pharma AG   (Germany)

^c Department of Dermatology ^*  (Germany)

Author keywords

Erythema index; Hypericin; Hypericum; Melanin index; Skin reflectance

Indexed keywords

HYPERICIN; HYPERICUM PERFORATUM EXTRACT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTERIC COATED TABLET; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERICUM PERFORATUM; LIGHT EXPOSURE; MALE; NORMAL HUMAN; PHOTOMETRY; PHOTOSENSITIVITY; PROSPECTIVE STUDY; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION; SOLAR ENERGY; STEADY STATE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; ERYTHEMA; FEMALE; HUMANS; HYPERICUM; HYPERPIGMENTATION; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; REFERENCE VALUES; SUNLIGHT; ULTRAVIOLET RAYS;

ANIMALIA; HYPERICUM; HYPERICUM PERFORATUM;

EID: 0037330646     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1091     Document Type: Article

References (30)

1. Araya OS, Ford EJH. 1981. An investigation of the type of photosensitization caused by the ingestion of St John's wort (Hypericum perforatum) by calves. J Comp Path 91: 135-141.
2. Bernd A, Simon S, Ramirez-Bosca A et al. 1999. Phototoxic effects of Hypericum extracts in cultures of human keratinocytes compared with those of psoralen. Photochem Photobiol 69: 218-221.
3. Brockmöller J, Reum T, Bauer S, Kerb R, Hbner WD, Roots I. 1997. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30: 56-63.
4. Chung PS, Saxton RE, Paiva MB et al. 1994. Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy. Laryngoscope 104: 1471-1476.
5. Diffey BL, Oliver RJ, Farr PM. 1984. A portable instrument for quantifying erythema induced by ultraviolet radiation. Br J Dermatol 111: 663-672.
6. Duran N, Song PS. 1986. Hypericin and its photodynamic action. Photochem Photobiol 43: 677-680.
7. TM. In Bioengineering of the Skin: Methods and Instrumentation, Berardesca E, Elsner P, Wilhelm KP, Maibach HI (eds). CRC Press: Boca Raton, FL, 127-129.
8. Fitzpatrick TB. 1988. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124: 869-871.
9. Fox FE, Niu Z, Tobia A, Rook AH. 1998. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 111: 327-332.
10. Giese AC. 1980. Hypericism. Photochem Photobiol Rev 5: 229-255.
11. Golsch S, Vocks E, Rakoski J, Brockow K, Ring J. 1997. Reversible increase of photosensitivity by St. John's Wort extract. Hautarzt 48: 249-252.
12. Greeson JM, Sanford B, Monti DA. 2001. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153: 402-414.
13. Gulick RM, McAuliffe V, Holden-Wiltse J et al. 1999. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults. Ann Intern Med 130: 510-514.
14. Hadjur C, Richard MJ, Parat MO, Jardon P, Favier A. 1996. Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem Photobiol 64: 375-381.
15. Jacobson JM, Feinman L, Liebes L et al. 2001. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 45: 517-524.
16. Kasper S. 2001. Hypericum perforatum - a review of clinical studies. Pharmacopsychiatry 34 (Suppl. 1): 51-55.
17. Kerb R, Brockmöller J, Staffeldt B, Ploch M, Roots I. 1996. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob Agents Chemother 40:2087-2093.
18. Koren H, Schenk GM, Jindra RH et al. 1996. Hypericin in phototherapy. J Photochem Photobiol (B) 36: 113-119.
19. Lavie G, Valentine F, Levin B et al. 1989. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci USA 86: 5963-5967.
20. Meruelo D, Lavie G, Lavie D. 1988. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA 85: 5230-5234.
21. Pace N. 1942. The etiology of hypericism, a photosensitivity produced by St. John's wort. Am J Physiol 136: 650-656.
22. Roth L. 1990. Hypericum-Hypericin. Ecomed: Landsberg/Lech, Germany.
23. Schempp CM, Müller K, Schulte-Mönting J, Schöpf E, Simon JC. 1999a. Salt water bathing prior to UV-B irradiation leads to a decrease of the MED and an increased erythema index without affecting skin pigmentation. Photochem Photobiol 69: 341-344.
24. Schempp CM, Müller K, Winghofer B, Schulte-Mönting J, Simon JC. 2001. Single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort) does not influence skin sensitivity to UVB, UVA, visible light and solar simulated radiation. Arch Dermatol 137: 512-513.
25. Schempp CM, Simon-Haarhaus B, Heine A, Schöpf E, Simon JC. 1999b. In vitro and in vivo activation of hypericin with the incoherent light source PDT 1200 SOA (520-750 nm) and with solar simulated radiation (290-2500 nm). Photodermatol Photoimmunol Photomed 15: 13-17.
26. Schempp CM, Winghofer B, Schöpf E, Simon E. 1999c. Hypericin and pseudohypericin levels in human serum and skin blister fluid after systemic application of Hypericum perforatum extract (St. John's Wort). Skin Pharmacol 12: 299-304.
27. Schulz V. 2001. Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. Phytomedicine 8: 152-160.
28. Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I. 1994. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. J Geriatr Psychiatry Neurol 7 (Suppl. 1): 47-53.
29. Thomas C, Randall S, MacGill S, Miller GC, Pardini RS. 1992. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinyloxidase. Photochem Photobiol 55: 47-53.
30. Yu H, Wolford ST, Kegode R, Zhao W, Osweiler D. 1996. Hypericin-induced phototoxicity in cultured fibroblasts and swine erythrocytes. Photochem Photobiol 64: 168-173.